CSL Behring UK

CSL Behring UK is a leading global biotechnology company that specializes in the development and delivery of innovative therapies for people with serious and rare diseases. With a strong commitment to improving patient outcomes, CSL Behring focuses on providing high-quality plasma-derived and recombinant therapies.

Founded in 1904, the company has a rich history of scientific excellence and a dedication to research and development. CSL Behring operates in over 60 countries, ensuring that patients worldwide have access to life-saving treatments.

The company's core activities include:

• Plasma Collection: CSL Behring operates a network of donation centres to collect human plasma, which is essential for producing its therapies.
• Research and Development: The company invests significantly in R&D to discover new therapies and improve existing ones.
• Manufacturing: CSL Behring has state-of-the-art manufacturing facilities that adhere to the highest quality standards.
• Patient Support: The company provides comprehensive support services to patients and healthcare professionals, ensuring they have the resources they need.

CSL Behring is driven by its mission to save lives and improve the quality of life for patients around the world. The company values integrity, innovation, and collaboration, working closely with healthcare providers and communities to achieve its goals.

With a workforce dedicated to excellence, CSL Behring UK continues to lead the way in biotherapeutics, making a significant impact on global health.